{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:04:44Z","timestamp":1760853884881,"version":"3.41.2"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Funds for Statutory Activity of Medical University of Lublin, Poland"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.pharep.2016.04.013","type":"journal-article","created":{"date-parts":[[2016,5,5]],"date-time":"2016-05-05T08:26:21Z","timestamp":1462436781000},"page":"960-963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Traxoprodil augments the antidepressant-like activity of agomelatine but not of mianserin or tianeptine in the forced swim test in mice"],"prefix":"10.1007","volume":"68","author":[{"given":"Weronika","family":"Stasiuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Serefko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Szopa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u017cbieta","family":"Wyska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"\u015awi\u0105der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Wla\u017a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Poleszak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2016.04.013_bib0100","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(96)07492-2","article-title":"Alternative projections of mortality and disability by cause 1990\u20132020: Global Burden of Disease Study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.pharep.2016.04.013_bib0105","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3389\/fnbeh.2014.00208","article-title":"Mechanisms underlying the antidepressant response and treatment resistance","volume":"8","author":"Levinstein","year":"2014","journal-title":"Front Behav Neurosci"},{"key":"10.1016\/j.pharep.2016.04.013_bib0110","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/appi.ajp.2015.15040465","article-title":"Ketamine and other NMDA antagonists: early clinical trials and possible mechanisms in depression","volume":"172","author":"Newport","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pharep.2016.04.013_bib0115","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.conb.2015.11.001","article-title":"NMDA antagonist treatment of depression","volume":"36","author":"Williams","year":"2016","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.pharep.2016.04.013_bib0120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/JCP.0b013e31818a6cea","article-title":"An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-d-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder","volume":"28","author":"Preskorn","year":"2008","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pharep.2016.04.013_bib0125","first-page":"778","article-title":"Amantadine as an additive treatment in patients suffering from drug-resistant unipolar depression","volume":"59","author":"Rog\u00f3\u017c","year":"2007","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2016.04.013_bib0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pnpbp.2013.06.001","article-title":"Effects of ifenprodil on the antidepressant-like activity of NMDA ligands in the forced swim test in mice","volume":"46","author":"Poleszak","year":"2013","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharep.2016.04.013_bib0135","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.pharep.2014.06.016","article-title":"The effects of ifenprodil on the activity of antidepressant drugs in the forced swim test in mice","volume":"66","author":"Poleszak","year":"2014","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2016.04.013_bib0140","doi-asserted-by":"crossref","DOI":"10.1007\/s11011-016-9810-5","article-title":"Traxoprodil, a selective antagonist of the NR2B subunit of the NMDA receptor, potentiates the antidepressant-like effects of certain antidepressant drugs in the forced swim test in mice","author":"Poleszak","year":"2016","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.pharep.2016.04.013_bib0145","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharep.2015.06.138","article-title":"Caffeine augments the antidepressant-like activity of mianserin and agomelatine in forced swim and tail suspension tests in mice","volume":"68","author":"Poleszak","year":"2016","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2016.04.013_bib0150","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.biopsych.2013.01.021","article-title":"Glutamate-based antidepressants: preclinical psychopharmacology","volume":"73","author":"Pilc","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharep.2016.04.013_bib0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/187152711794488674","article-title":"The emerging role of melatonin agonists in the treatment of major depression: focus on agomelatine","volume":"10","author":"de Berardis","year":"2011","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.pharep.2016.04.013_bib0160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2005.11.006","article-title":"Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application","volume":"110","author":"Millan","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.pharep.2016.04.013_bib0165","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/mp.2009.80","article-title":"The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation","volume":"15","author":"McEwen","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharep.2016.04.013_bib0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1471-2202-14-75","article-title":"Chronic treatment with agomelatine or venlafaxine reduces depolarization-evoked glutamate release from hippocampal synaptosomes","volume":"14","author":"Milanese","year":"2013","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.pharep.2016.04.013_bib0175","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/j.pain.2012.08.016","article-title":"Exacerbated mechanical hyperalgesia in rats with genetically predisposed depressive behavior: role of melatonin and NMDA receptors","volume":"153","author":"Wang","year":"2012","journal-title":"Pain"},{"key":"10.1016\/j.pharep.2016.04.013_bib0180","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/S1734-1140(11)70716-2","article-title":"NMDA and AMPA receptors are involved in the antidepressant-like activity of tianeptine in the forced swim test in mice","volume":"63","author":"Wla\u017a","year":"2011","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2016.04.013_bib0185","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0924-977X(92)90034-6","article-title":"Effects of MK-801 and antidepressant drugs in the forced swimming test in rats","volume":"2","author":"Maj","year":"1992","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2016.04.013_bib0190","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016300317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114016300317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:36:30Z","timestamp":1752611790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2016.04.013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S1734114016300317"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2016.04.013","relation":{},"ISSN":["1734-1140"],"issn-type":[{"type":"print","value":"1734-1140"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Traxoprodil augments the antidepressant-like activity of agomelatine but not of mianserin or tianeptine in the forced swim test in mice","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2016.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}